Zobrazeno 1 - 10
of 42
pro vyhledávání: '"O V Sapelnikov"'
Autor:
G V Ryabykina, Z O Shokhzodaeva, O V Sapelnikov, M I Makeev, E Sh Kozhemyakina, E V Shchedrina, V E Volkov, R S Akchurin
Publikováno v:
Терапевтический архив, Vol 90, Iss 12, Pp 12-16 (2018)
Aim. To evaluate the diagnostic utility of long-term remote monitoring of ECG compared with 24 hour Holter monitoring for the detection of cardiac arrhythmias and conduction disturbance in patients with atrial fibrillation (AF) after catheter radiofr
Externí odkaz:
https://doaj.org/article/204351660cf0425e9c325da8c357ea31
Publikováno v:
Евразийский Кардиологический Журнал, Vol 0, Iss 2, Pp 12-18 (2023)
Aim. To evaluate the efficacy of catheter ablation (CA) of atrial fibrillation (AF) in patients with left ventricular systolic dysfunction and the effect of the procedure on the course of chronic heart failure (CHF) compared with the use of antiarrhy
Externí odkaz:
https://doaj.org/article/dd6473ed4ab342248a866809d8770298
Autor:
A. V. Vereshchagina, T. M. Uskach, O. V. Sapelnikov, V. A. Amanatova, I. R. Grishin, A. A. Kulikov, V. S. Kostin, R. S. Akchurin
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 18, Iss 4, Pp 427-432 (2022)
Aim. To study the safety and tolerability of the subcutaneous implantable cardioverter defibrillator (S-ICD) after implantation.Material and methods. The results of 33 patients with implanted S-ICD 6 months follow-up. The criteria for inclusion in th
Externí odkaz:
https://doaj.org/article/20f3bc37b37f4819b2dd1876096a6234
Autor:
A. A. Kulikov, O. V. Sapelnikov, T. M. Uskach, D. I. Cherkashin, I. R. Grishin, R. S. Akchurin
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 17, Iss 2, Pp 270-277 (2021)
Atrial fibrillation is the most common arrhythmia in clinical practice. It is associated with an increased risk of stroke, chronic heart failure, and sudden cardiac death. Our options of restoring and maintaining sinus rhythm have a very limited effe
Externí odkaz:
https://doaj.org/article/07572e273e87453b857fa6e7d4a8b247
Autor:
O. V. Sapelnikov, A. A. Kulikov, D. I. Cherkashin, I. R. Grishin, O. A. Nikolaeva, R. S. Akchurin
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 16, Iss 1, Pp 118-125 (2020)
Atrial fibrillation (AF) is the most common arrhythmia. It is diagnosed in more than 33 million people worldwide and is the leading cause of hospitalization for arrhythmias. AF is characterized by fast and irregular atrial activation without discrete
Externí odkaz:
https://doaj.org/article/3c93786c7bba4dc98079d8fc766a6daa
Autor:
O. V. Sapelnikov, A. A. Kulikov, O. O. Favorova, N. A. Matveeva, D. I. Cherkashin, O. A. Nikolaeva, R. S. Akchurin
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 15, Iss 3, Pp 407-415 (2019)
Atrial fibrillation (AF) is one of the most common arrhythmia that occurs in patients with cardiovascular diseases. Congenital forms of AF are quite rare. Many studies have shown that genetic, epigenetic and transcription factors may play an importan
Externí odkaz:
https://doaj.org/article/9799b609f6684ec2acbcd43e4aa95e01
Autor:
T. E. Imaev, A. E. Komlev, V. V. Romakina, P. M. Lepilin, M. I. Makeev, A. S. Kolegaev, A. A. Margolina, O. V. Sapelnikov, I. S. Fedotenkov, M. A. Saidova, R. S. Akchurin
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 2, Pp 31-37 (2019)
Aim. In the issue we report first in Russia experience of transcatheter “valve-invalve” implantation (TVIV) for treatment of severe tricuspid stenosis due to the structural deterioration of surgical tricuspid bioprosthesis.Material and methods. T
Externí odkaz:
https://doaj.org/article/fc2b8d33094741a3aecc7ac84d3357a6
Autor:
O. V. Sapelnikov, O. A. Nikolaeva, D. F. Ardus, D. I. Cherkashin, I. R. Grishin, N. B. Shlevkov, A. A. Zhambeev, H. F. Salami, R. S. Akchurin
Publikováno v:
Патология кровообращения и кардиохирургия, Vol 22, Iss 3, Pp 75-80 (2018)
Mitral valve disease, including dysfunction of the mitral valve, is often accompanied by atrial fibrillation. Among the patients with prosthetic mitral valves, atrial fibrillation occurs in 30–50% cases. Development of atrial arrhythmias and incisi
Externí odkaz:
https://doaj.org/article/0b7d25c2c30b4c59a4f94cf98babb34e
Efficacy and Safety of Nonfluoroscopic Approach During Catheter Ablation of Ventricular Tachycardias
Autor:
E. G. Huseynli, O. V. Sapelnikov, V. A. Amanatova, D. F. Ardus, M. R. Khachirov, I. R. Grishin, D. I. Cherkashin, M. A. Saidova, O. V. Stukalova, N. B. Shlevkov, T. M. Uskach, R. S. Akchurin
Publikováno v:
Kardiologiia. 63:36-45
Aim To evaluate a possibility of using radiofrequency catheter ablation guided by intracardiac echocardiography (ICE), its efficacy and safety for treatment of ventricular tachycardia (VT) of various etiology.Material and methods Catheter interventio
Autor:
O. V. Sapelnikov, D. F. Ardus, V. S. Kostin, T. M. Uskach, D. I. Cherkashin, I. R. Grishin, K. B. Bogatyreva, A. V. Emelyanov, A. A. Kulikov, O. A. Nikolaeva, R. S. Akchurin
Publikováno v:
Российский кардиологический журнал, Vol 25, Iss 12 (2020)
The article demonstrates available literature data on the nonfluoroscopic catheter ablation of atrial fibrillation (AF). The main disadvantages of standard fluoroscopic catheter ablation are shown. The research results on the use of intracardiac echo
Externí odkaz:
https://doaj.org/article/e79e6bd4355d45cbb3aeb6d2a5484178